Estrella Immunopharma
ESLA
ESLA
11 hedge funds and large institutions have $568K invested in Estrella Immunopharma in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$237K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$84.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.26K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.72K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$4 |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$22.4K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$12.8K |
| 3 |
BlackRock
New York
|
-$431 |
| 4 |
JPMorgan Chase & Co
New York
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $257K | +$237K | +255,894 | +1,180% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $92.9K | +$6.26K | +6,755 | +7% |
|
|
3
Citadel Advisors
Miami,
Florida
| $84.9K | +$84.9K | +91,599 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $38K | -$22.4K | -24,133 | -37% |
|
|
ASM
5
ATW SPAC Management
New York
| $37.1K | – | – | – |
|
|
6
BlackRock
New York
| $22.9K | -$431 | -465 | -2% |
|
7
State Street
Boston,
Massachusetts
| $20.7K | – | – | – |
|
|
MCP
8
Maso Capital Partners
Hong Kong
| $9.27K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $5.23K | +$1.72K | +1,858 | +49% |
|
|
10
Bank of America
Charlotte,
North Carolina
| $81 | +$4 | +4 | +5% |
|
|
11
JPMorgan Chase & Co
New York
| $21 | -$3 | -3 | -12% |
|
|
TSS
12
Two Sigma Securities
New York
| – | -$12.8K | -10,640 | Closed |
|